Updated · National Institutes of Health (NIH) (.gov) · Jul 22
NIH Launches Bio Genesis Mission to Double Biomedical Innovation Pace in 5 to 10 Years
Updated
Updated · National Institutes of Health (NIH) (.gov) · Jul 22
NIH Launches Bio Genesis Mission to Double Biomedical Innovation Pace in 5 to 10 Years
3 articles · Updated · National Institutes of Health (NIH) (.gov) · Jul 22
Summary
The NIH said its new Bio Genesis Mission aims to cut the time from biomedical discovery to health impact by accelerating innovation over the next five to 10 years.
The initiative is NIH’s contribution to the broader Genesis Mission, a White House-backed effort under Executive Order 14363 to use AI and advanced computing to speed U.S. science and technology leadership.
Six focus areas anchor the program: predicting living systems, scaling biology for domestic biomanufacturing, detecting biological threats, using AI against pediatric cancer, speeding drug discovery, and probing chronic disease causes.
NIH said it will build the data, governance, partnerships and clinical-research infrastructure needed to deploy AI at scale while protecting sensitive biomedical data and moving benefits to patients faster.
With AI's known data vulnerabilities, what guarantees will protect sensitive patient health information in this national mission?
AI drugs show early promise but often fail in later human trials. How will this mission overcome that critical bottleneck?
Accelerating Biomedical Breakthroughs: How the NIH Bio Genesis Mission Aims to Halve Discovery-to-Patient Timelines with AI
Overview
The Bio Genesis Mission, launched by the National Institutes of Health as part of the broader Genesis Mission led by the White House Office of Science and Technology Policy, is strategically aligned with the American Science and Security Platform. This national framework integrates advanced computing, scientific facilities, data resources, and artificial intelligence to accelerate discovery across federal research. The Bio Genesis Mission focuses on tackling major science and technology challenges in biomedical research, aiming to advance discovery and translation for human health. By leveraging these powerful resources, the mission seeks to deliver faster, more impactful biomedical innovations to benefit patients nationwide.